Sera Prognostics (SERA) News
NASDAQ: SERAHealth CareMedical SpecialitiesUSD
1.81-0.08 (-4.23%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SERA news summary
We found 4 recent headlines mentioning Sera Prognostics (SERA): 1 in the past week and 3 in the past 30 days, most often from Nasdaq, PR Newswire. For price context, SERA is down 4.23% at $1.81. The most recent story, "Sera: 3 Key Takeaways for Long-Term Investors", was published by Nasdaq on Nov 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Sera Prognostics headlines
- Sera: 3 Key Takeaways for Long-Term InvestorsKey PointsTest volume increased approximately fivefold from the first quarter of 2026.Nasdaq
- Sera Prognostics (SERA) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Sera Prognostics Reports Third Quarter 2026 Financial ResultsSera Prognostics, Inc. reported its financial results for the third quarter ended September 30, 2026. Total PreTRM test revenue in the quarter was $42,000 representing a 163% increase on a…Nasdaq
- SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026SALT LAKE CITY, Oct. 21, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy…PR Newswire